Alger Associates, Inc. 13D and 13G filings for Core Laboratories N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-12 4:02 pm Sale | 2023-05-31 | 13G | Core Laboratories N.V. CLB | Alger Associates, Inc. | 0 0.000% | -3,853,977 (Position Closed) | Filing |
| 2023-02-14 4:08 pm Sale | 2022-12-31 | 13G | Core Laboratories N.V. CLB | Alger Associates, Inc. | 3,853,977 8.300% | -165,258 (-4.11%) | Filing |
| 2022-01-10 4:03 pm Sale | 2021-12-31 | 13G | Core Laboratories N.V. CLB | Alger Associates, Inc. | 4,019,235 8.700% | -2,491,997 (-38.27%) | Filing |
| 2021-06-10 4:15 pm Purchase | 2021-05-31 | 13G | Core Laboratories N.V. CLB | Alger Associates, Inc. | 6,511,232 14.060% | 4,147,086 (+175.42%) | Filing |
| 2021-02-16 4:44 pm Purchase | 2020-12-31 | 13G | Core Laboratories N.V. CLB | Alger Associates, Inc. | 2,364,146 5.310% | 2,364,146 (New Position) | Filing |